SCHEMBL7035850

SCHEMBL7035850

CC(C)(C)OC(=O)N1CCC(N)CC1.CC(C)(C)OC(=O)N1CCC(NCc2ccc(Cl)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ STS P08842 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ KDM1A O60341 1/20 0.46
▸ BCHE P06276 1/20 0.46
▸ ACHE P22303 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ CNR1 P21554 2/20 0.45
▸ GPR119 Q8TDV5 1/20 0.45
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652849 0.94 HTT (0.57) HTTSMN1; SMN2NPSR1STSALDH1A1
SCHEMBL1276278 0.91 HTT (0.48) HTTSMN1; SMN2NPSR1STSALDH1A1
SCHEMBL652820 0.88 HTT (0.53) HTTSMN1; SMN2NPSR1STSALDH1A1
SCHEMBL651891 0.88 HTT (0.53) HTTSMN1; SMN2NPSR1STSALDH1A1
SCHEMBL2793493 0.84 GPR119 (0.57) HTTSMN1; SMN2ALDH1A1NPC1MAPT
SCHEMBL4139902 0.83 DNMT3A (0.56) HTTALDH1A1NPC1MAPTMAPK1
SCHEMBL5013239 0.83 ALDH1A1 (0.51) HTTSMN1; SMN2STSALDH1A1NPC1
SCHEMBL616004 0.83 STS (0.60) HTTSMN1; SMN2STSALDH1A1NPC1
SCHEMBL7381166 0.82 ALDH1A1 (0.69) HTTSMN1; SMN2STSALDH1A1MAPT
SCHEMBL13434283 0.81 HTT (0.51) HTTSMN1; SMN2NPSR1STSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 — — EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 — — WO disclosed
Send feedback